{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:31:41Z","timestamp":1789115501882,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["U54MD007579"],"award-info":[{"award-number":["U54MD007579"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["5R25MD007607-22"],"award-info":[{"award-number":["5R25MD007607-22"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5U54GM133807-03"],"award-info":[{"award-number":["5U54GM133807-03"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5P20GM103475-21"],"award-info":[{"award-number":["5P20GM103475-21"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Hermansky-Pudlak Syndrome (HPS) type 1 (HPS-1) is an autosomal recessive disorder characterized by oculocutaneous albinism, platelet dysfunction, and pulmonary fibrosis (HPS-PF), the leading cause of mortality in these patients. HPS-PF manifests earlier than idiopathic pulmonary fibrosis, typically between 30 and 40 years of age. The etiology and drivers of HPS-PF progression remain poorly understood, and no FDA-approved therapies exist. Neutrophil extracellular traps (NETs) and neutrophil-derived mediators have emerged as key players in fibrosis, promoting lung injury, inflammation, and fibroblast activation. This study evaluates the role of neutrophil activation in age-related changes in patients with HPS-1, focusing on differences in inflammatory markers, neutrophil granules, and NETosis capacity. We observed significantly elevated levels of NETs, neutrophil granule proteins (NE, NGAL, LF), and inflammatory cytokines (IL-8, IL-6) in patients with HPS-1 older than 40 years compared to younger patients and healthy controls. Additionally, fibrosis-related markers (MMP-7 and MMP-8) were significantly higher in older patients. Elevated levels of anandamide (AEA), a circulating marker of HPS-PF, were positively associated with neutrophil granule markers in older patients, suggesting its association with fibrosis. Neutrophils from older patients also demonstrated increased NETosis capacity. These findings suggest that age-related neutrophil activation may contribute to an inflammatory environment that promotes fibrosis progression in HPS-1.<\/jats:p>","DOI":"10.1186\/s13023-025-03758-5","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T09:58:22Z","timestamp":1747043902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Age-related neutrophil activation in Hermansky-Pudlak Syndrome Type-1"],"prefix":"10.1186","volume":"20","author":[{"given":"Lourdes Marinna","family":"Caro-Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Malavez-Cajigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Lacourt-Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea P.","family":"Rivera-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorca E.","family":"Marcano-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"L\u00f3pez-Colon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Mu\u00f1iz-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enid","family":"Rivera-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Egozcue-Dionisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Rom\u00e1n-Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfredo","family":"De Jes\u00fas-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos J.","family":"Ramos-Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"issue":"2","key":"3758_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1055\/s-0040-1708088","volume":"41","author":"J De Rojas","year":"2020","unstructured":"De Rojas J, W. and, Young LR. Hermansky-Pudlak syndrome. Semin Respir Crit Care Med. 2020;41(2):238\u201346.","journal-title":"Semin Respir Crit Care Med"},{"key":"3758_CR2","doi-asserted-by":"publisher","first-page":"644671","DOI":"10.3389\/fphar.2021.644671","volume":"12","author":"P Vel\u00e1zquez-D\u00edaz","year":"2021","unstructured":"Vel\u00e1zquez-D\u00edaz P, et al. Hermansky-Pudlak syndrome and lung disease: pathogenesis and therapeutics. Front Pharmacol. 2021;12:644671.","journal-title":"Front Pharmacol"},{"key":"3758_CR3","doi-asserted-by":"crossref","unstructured":"Vicary GW, et al. Pulmonary fibrosis in Hermansky-Pudlak syndrome. Annals of the American Thoracic Society; 2016.","DOI":"10.1513\/AnnalsATS.201603-186FR"},{"key":"3758_CR4","unstructured":"Wang T, Hermansky Pudlak Syndrome. 2020 [2024 October 2, 2024]; Available from: https:\/\/www.thoracic.org\/patients\/lung-disease-week\/2020\/hermansky-pudlak-syndrome-week\/general-info.php"},{"issue":"1","key":"3758_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1542\/peds.2012-4003","volume":"132","author":"SL Seward Jr","year":"2013","unstructured":"Seward SL Jr., Gahl WA. Hermansky-Pudlak syndrome: health care throughout life. Pediatrics. 2013;132(1):153\u201360.","journal-title":"Pediatrics"},{"key":"3758_CR6","doi-asserted-by":"crossref","unstructured":"Keir HR, Chalmers JD. Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy. Eur Respir Rev, 2022. 31(163).","DOI":"10.1183\/16000617.0241-2021"},{"issue":"1","key":"3758_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5114\/ceji.2014.42136","volume":"39","author":"A Manda","year":"2014","unstructured":"Manda A, et al. Neutrophil extracellular traps in physiology and pathology. Cent Eur J Immunol. 2014;39(1):116\u201321.","journal-title":"Cent Eur J Immunol"},{"key":"3758_CR8","doi-asserted-by":"crossref","unstructured":"Islam MM, Takeyama N. Role of neutrophil extracellular traps in health and disease pathophysiology: recent insights and advances. Int J Mol Sci, 2023; 24(21).","DOI":"10.3390\/ijms242115805"},{"issue":"3","key":"3758_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/path.4359","volume":"233","author":"A Chrysanthopoulou","year":"2014","unstructured":"Chrysanthopoulou A, et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts. J Pathol. 2014;233(3):294\u2013307.","journal-title":"J Pathol"},{"issue":"2","key":"3758_CR10","doi-asserted-by":"publisher","first-page":"e32366","DOI":"10.1371\/journal.pone.0032366","volume":"7","author":"M Saffarzadeh","year":"2012","unstructured":"Saffarzadeh M, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: A predominant role of histones. PLoS ONE. 2012;7(2):e32366.","journal-title":"PLoS ONE"},{"issue":"2","key":"3758_CR11","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1111\/jcmm.14858","volume":"24","author":"S Zhang","year":"2020","unstructured":"Zhang S, et al. Neutrophil extracellular traps activate lung fibroblast to induce polymyositis-related interstitial lung diseases via TLR9-miR-7-Smad2 pathway. J Cell Mol Med. 2020;24(2):1658\u201369.","journal-title":"J Cell Mol Med"},{"key":"3758_CR12","doi-asserted-by":"crossref","unstructured":"Matson SM, et al. Neutrophil extracellular traps linked to idiopathic pulmonary fibrosis severity and survival. medRxiv; 2024.","DOI":"10.1101\/2024.01.24.24301742"},{"key":"3758_CR13","doi-asserted-by":"crossref","unstructured":"Navarro SM, et al. Histological findings of etosis in Hermansky-Pudlak syndrome with pulmonary fibrosis: A Follow-Up case report. J Chest Surg; 2024.","DOI":"10.5090\/jcs.24.059"},{"key":"3758_CR14","doi-asserted-by":"crossref","unstructured":"Cinar R et al. Anandamide is a potential blood biomarker of Hermansky-Pudlak syndrome pulmonary fibrosis. Am J Respir Crit Care Med, 2025.","DOI":"10.1101\/2024.05.16.24307300"},{"key":"3758_CR15","doi-asserted-by":"publisher","first-page":"109687","DOI":"10.1016\/j.clim.2023.109687","volume":"254","author":"H Lin","year":"2023","unstructured":"Lin H, et al. NETosis promotes chronic inflammation and fibrosis in systemic lupus erythematosus and COVID-19. Clin Immunol. 2023;254:109687.","journal-title":"Clin Immunol"},{"key":"3758_CR16","doi-asserted-by":"publisher","first-page":"663303","DOI":"10.3389\/fimmu.2021.663303","volume":"12","author":"L Pandolfi","year":"2021","unstructured":"Pandolfi L, et al. Neutrophil extracellular traps induce the Epithelial-Mesenchymal transition: implications in Post-COVID-19 fibrosis. Front Immunol. 2021;12:663303.","journal-title":"Front Immunol"},{"issue":"12","key":"3758_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.4049\/immunohorizons.2200083","volume":"6","author":"HI Warheit-Niemi","year":"2022","unstructured":"Warheit-Niemi HI, et al. Fibrotic lung disease alters neutrophil trafficking and promotes neutrophil elastase and extracellular trap release. ImmunoHorizons. 2022;6(12):817\u201334.","journal-title":"ImmunoHorizons"},{"issue":"1","key":"3758_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.18632\/aging.102632","volume":"12","author":"MA Roy-O\u2019Reilly","year":"2020","unstructured":"Roy-O\u2019Reilly MA, et al. Aging exacerbates neutrophil pathogenicity in ischemic stroke. Aging. 2020;12(1):436\u201361.","journal-title":"Aging"},{"issue":"10","key":"3758_CR19","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s40520-022-02201-0","volume":"34","author":"M Sabbatini","year":"2022","unstructured":"Sabbatini M, et al. Aging hampers neutrophil extracellular traps (NETs) efficacy. Aging Clin Exp Res. 2022;34(10):2345\u201353.","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"3758_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12950-023-00329-y","volume":"20","author":"S Yan","year":"2023","unstructured":"Yan S, et al. Neutrophil extracellular traps and pulmonary fibrosis: an update. J Inflamm. 2023;20(1):2.","journal-title":"J Inflamm"},{"issue":"5 Suppl","key":"3758_CR21","first-page":"456","volume":"64","author":"M Bickel","year":"1993","unstructured":"Bickel M. The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol. 1993;64(5 Suppl):456\u201360.","journal-title":"J Periodontol"},{"key":"3758_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fimmu.2018.00076","volume":"9","author":"S El-Chemaly","year":"2018","unstructured":"El-Chemaly S, et al. The immunome in two inherited forms of pulmonary fibrosis. Front Immunol. 2018;9:76.","journal-title":"Front Immunol"},{"issue":"3 Pt 1","key":"3758_CR23","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1164\/ajrccm.157.3.9705014","volume":"157","author":"MW Ziegenhagen","year":"1998","unstructured":"Ziegenhagen MW, et al. Serum level of Interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Respir Crit Care Med. 1998;157(3 Pt 1):762\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3758_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s42003-025-07589-9","volume":"8","author":"BJH Banaschewski","year":"2025","unstructured":"Banaschewski BJH, et al. Emergence of inflammatory fibroblasts with aging in Hermansky-Pudlak syndrome associated pulmonary fibrosis. Commun Biology. 2025;8(1):284.","journal-title":"Commun Biology"},{"key":"3758_CR25","doi-asserted-by":"crossref","unstructured":"Sorkhdini P et al. Type 2 innate immunity promotes the development of pulmonary fibrosis in Hermansky-Pudlak syndrome. JCI Insight, 2024; 9(22).","DOI":"10.1172\/jci.insight.178381"},{"issue":"1","key":"3758_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-019-1143-0","volume":"14","author":"R Summer","year":"2019","unstructured":"Summer R, et al. Matrix metalloproteinase activity in the lung is increased in Hermansky-Pudlak syndrome. Orphanet J Rare Dis. 2019;14(1):162.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3758_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/resp.12920","volume":"22","author":"A Tzouvelekis","year":"2017","unstructured":"Tzouvelekis A, et al. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis. Respirology. 2017;22(3):486\u201393.","journal-title":"Respirology"},{"key":"3758_CR28","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3389\/fimmu.2020.01749","volume":"11","author":"MT Masucci","year":"2020","unstructured":"Masucci MT, et al. The emerging role of neutrophil extracellular traps (NETs) in tumor progression and metastasis. Front Immunol. 2020;11:1749.","journal-title":"Front Immunol"},{"issue":"1","key":"3758_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0749.2005.00289.x","volume":"19","author":"ML Wei","year":"2006","unstructured":"Wei ML. Hermansky\u2013Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res. 2006;19(1):19\u201342.","journal-title":"Pigment Cell Res"},{"issue":"12","key":"3758_CR30","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41573-019-0036-1","volume":"18","author":"SR Bonam","year":"2019","unstructured":"Bonam SR, Wang F, Muller S. Lysosomes as a therapeutic target. Nat Rev Drug Discov. 2019;18(12):923\u201348.","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"3758_CR31","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1161\/ATVBAHA.120.314883","volume":"40","author":"P Haider","year":"2020","unstructured":"Haider P, et al. Neutrophil extracellular trap degradation by differently polarized macrophage subsets. Arterioscler Thromb Vasc Biol. 2020;40(9):2265\u201378.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"3758_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12931-022-02002-z","volume":"23","author":"S Abudi-Sinreich","year":"2022","unstructured":"Abudi-Sinreich S, et al. Progressive pulmonary fibrosis in a murine model of Hermansky-Pudlak syndrome. Respir Res. 2022;23(1):112.","journal-title":"Respir Res"},{"issue":"2","key":"3758_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.arbres.2021.03.018","volume":"58","author":"G Bermudo","year":"2022","unstructured":"Bermudo G, et al. Different faces of idiopathic pulmonary fibrosis with preserved forced vital capacity. Arch Bronconeumol. 2022;58(2):135\u201341.","journal-title":"Arch Bronconeumol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03758-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03758-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03758-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T09:58:25Z","timestamp":1747043905000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03758-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3758"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03758-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review of Ponce Health Sciences University, protocol code 2303138796.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"226"}}